BTK Inhibitor Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Tyrosine-Protein Kinase BTK Protein

Filter by location:

Duarte, California1 trial

Pacritinib in Combination With a BTK Inhibitor for the Treatment of Patients With Relapsed or Refractory Mantle Cell Lymphoma

City of Hope Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.